anatoxin a has been researched along with Cognition Disorders in 1 studies
*Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akireddy, S; Bhatti, BS; Gatto, GJ; Hammond, P; Hauser, TA; Jordan, KG; Kombo, D; Mazurov, AA; Miao, L; Miller, CH; Murthy, S; Speake, JD; Strachan, JP; Xiao, YD; Yohannes, D; Zhang, J | 1 |
1 other study(ies) available for anatoxin a and Cognition Disorders
| Article | Year |
|---|---|
Discovery of 3-(5-chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a novel highly selective α4β2 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders.
Topics: Animals; Brain; Bridged Bicyclo Compounds, Heterocyclic; Cell Line; Cognition Disorders; Cricetinae; Cricetulus; Exploratory Behavior; Humans; Male; Models, Molecular; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Stereoisomerism; Structure-Activity Relationship | 2012 |